Activity Description

Series Description: This certified CME series focuses on the identification and stratification of patients at risk of Tumor Lysis Syndrome (TLS) and the management of TLS once identified. Expert faculty will discuss the identification of treatment strategies based on patient risk factors and the prevention of acute kidney injury in patients with TLS.

After participating in the Webcast on Nephropathy and TLS, watch your choice of 2 distinct 30-minute patient case
studies to review how to stratify cancer patients and apply prophylactic measures based on their risk of developing TLS.

  •  

Accreditation/Designation Statements: Med-IQ is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Med-IQ designates this activity for a maximum of 2.0 AMA PRA Category 1 Credits™.

In collaboration with Oncology Today

Oncology Today

This activity is supported by an educational grant from sanofi-aventis U.S.

sanofi aventis

© 2009 Med-IQ. All rights reserved.

Med-IQ delivers education that brings measurable change in healthcare provider compentency with the goal of improving performance and patient outcomes.

e-mail info@med-iq.com www.med-iq.com